July 9, 2011 -- Sihuan Pharmaceutical Holdings will sell a 50% stake in a drug distribution subsidiary to Shandong Buchang Pharmaceutical at a price of 637.5 million RMB ($98.6 million). Both companies have expertise in the cardio-cerebral vascular sector. It was a good deal for Sihuan, which purchased the assets last month for 775 million RMB ($120 million). More details....
Stock Symbol: (HK: 0640)
